Sign In
Buy FIXX
$0.93
+0 (+0%)
At Close: Jun 24, 2024
Homology Medicines Announces Proposed Public Offering of Common Stock
04:19pm, Tuesday, 06'th Apr 2021
BEDFORD, Mass., April 06, 2021 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage genetic medicines company, today announced that the Company intends to offer and sell, sub
Homology Medicines (FIXX) Reports Q4 Loss, Tops Revenue Estimates
07:41pm, Thursday, 11'th Mar 2021
Homology Medicines (FIXX) delivered earnings and revenue surprises of 4.62% and 130.59%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Homology Medicines Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
04:10pm, Thursday, 11'th Mar 2021
- Phase 2 PKU Gene Therapy Trial Recruiting Patients With Initial Data Expected by Year End -
Homology Medicines Regains Worldwide Rights to Ophthalmology Program Based on its In Vivo Nuclease-Free Gene Editing Platform
07:30am, Monday, 01'st Mar 2021
- Company plans to continue advancing ophthalmic program toward a development candidate for lead indication -
- IND-Enabling Studies Demonstrated Potential of a Single I.V. Administration of HMI-203 to Address Peripheral and CNS Components of Disease -
Homology Medicines Reports Third Quarter 2020 Financial Results and Recent Highlights
04:05pm, Monday, 09'th Nov 2020
- Based on Positive Data , Advancing pheNIX Gene Therapy Clinical Trial for PKU to Dose Expansion Phase -
Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal
10:36am, Monday, 09'th Nov 2020
Homology Medicines (FIXX) is making news on Monday after announcing a massive $60 million investment deal with Pfizer (PFE) The post Homology Medicines News: 9 Things for FIXX Stock Investors to Know
- Marked Reductions in Phe Observed at Two Dose s -
Homology Medicines Announces Upcoming Oral Presentation on pheNIX Gene Therapy Clinical Trial for Adults with PKU
09:15am, Thursday, 05'th Nov 2020
Homology Webcast / Conference Call Scheduled for Friday, November 6 at 4:30 p.m. ET
San Francisco, California--(Newsfile Corp. - October 29, 2020) - Hagens Berman urges Homology Medicines, Inc. (NASDAQ: FIXX) investors with significant losses to submit your losses now. The firm is in
San Francisco, California--(Newsfile Corp. - October 27, 2020) - Hagens Berman urges Homology Medicines, Inc. (NASDAQ: FIXX) investors with significant losses to submit your losses now. The firm is in
Global PKU Supplements Market Future Scenario Along with Top Key Players : Vitaflo, Mead Johnson, Nutricia
11:09am, Wednesday, 07'th Oct 2020
Oct 07, 2020 (WiredRelease via Comtex) --
The latest research report provides a complete assessment of the Global PKU Supplements market for the forecast...
Regenerative Medicine: Does BioMarin Complete Response Letter Change The Outlook?
01:24pm, Tuesday, 25'th Aug 2020
Over a dozen regenerative medicine drugs have been launched, generating revenues approaching $4 billion in 2019.
Genomic Medicine: Summer 2020 Update
09:36am, Thursday, 13'th Aug 2020
FDA approvals, new guidance statements, and RMAT requests all show the pace of genomics is accelerating.
Global Hemoglobinopathy Treatment Drugs Market to Surpass US$ 6.4 Billion by 2027, Says Coherent Market Insights
12:00am, Tuesday, 11'th Aug 2020
The global hemoglobinopathy treatment drugs market is projected to exhibit a CAGR of 8.4% during the forecast period (2020-2027).
